FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer
- 30 November 2006
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 32 (9) , 989-995
- https://doi.org/10.1016/j.ejso.2006.05.017
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed TomographyNew England Journal of Medicine, 2003
- Metabolic and molecular basis of insulin resistanceJournal of Nuclear Cardiology, 2003
- Expression of hexokinase II and Glut-1 in untreated human breast cancerNuclear Medicine and Biology, 2002
- Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancerLung Cancer, 2001
- The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporationNuclear Medicine and Biology, 2001
- Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.Journal of Clinical Oncology, 1998
- Regional Lymph Node Classification for Lung Cancer StagingChest, 1997
- Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma.Radiology, 1992